Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
998 INR | +1.45% | -0.87% | +44.65% |
May. 13 | Zydus Lifesciences Gets US FDA Nod to Market Dexamethasone Tablets | MT |
May. 10 | India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.65% | 11.85B | |
+21.31% | 44.4B | |
+24.45% | 23.03B | |
+18.00% | 15.14B | |
+13.73% | 13.12B | |
-7.81% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.52B | |
+10.29% | 4.91B |
- Stock Market
- Equities
- ZYDUSLIFE Stock
- News Zydus Lifesciences Limited
- Jefferies Adjusts Zydus Lifesciences’ Price Target to INR750 From INR660, Keeps at Hold